TNF and immunodeficiency disease: In recent years, some anti-inflammatory measures against SIRS, including hormones, monoclonal antibody of endotoxin and TNF-α, and other inflammatory mediators antagonists, have failed in clinical trials, and some of the tests even showed harmful effects, suggesting that we should not ignore the immunodeficiency status when CARS is dominant.